Diabetes

MedTech

Abbott spinal cord stimulator nets FDA approval in diabetes pain

The company's Proclaim XR received a new approval from the FDA covering peripheral neuropathy caused by diabetes.
Conor Hale Jan 26, 2023 11:21am

Tidepool lands long-awaited FDA nod for diabetes management app

Jan 25, 2023 10:33am

JPM23: Dexcom preps for the 'chaos' of the G7 global rollout

Jan 10, 2023 5:47pm

Embecta beats its own estimates in first 6 months of BD spinout

Dec 22, 2022 11:07am

2023 forecast: Will tech makers finally close the diabetes loop?

Dec 21, 2022 8:30am

Tandem offers $216M for insulin patch pump maker AMF Medical

Dec 13, 2022 10:50am